DOJ Requires UnitedHealth to Divest Clinics in Amedisys Merger
Published Date: 11/19/2025
Notice
Summary
The U.S. government is making sure UnitedHealth’s buyout of Amedisys doesn’t hurt competition. To fix this, UnitedHealth must sell 164 care locations across 19 states to other companies and pay a $1.1 million fine for breaking rules. These changes protect patients and keep the healthcare market fair and open.
Analyzed Economic Effects
6 provisions identified: 6 benefits, 0 costs, 0 mixed.
Sale of 164 care locations nationwide
If you use home health, hospice, or palliative care, UnitedHealth must sell 152 home health, 11 hospice, and 1 palliative care locations (164 total) across 19 states to BrightSpring, Pennant, or another buyer acceptable to the United States. The divestitures are meant to keep competition in local care markets.
Employee contracts transferred with sales
If you work at one of the divested agencies, your employment contract is part of the sale: the divested assets must include employment contracts for more than 1,800 "Relevant Personnel" (full-time, part-time, or contract employees) to help the buyers keep staff.
Up to one-year transition support for buyers
The seller must provide transition services to the buyers for up to 365 calendar days, with the United States able to approve up to an additional 180 days. An acquirer may end transition services with 30 days' notice. This helps buyers keep services running during the handover.
Amedisys pays $1.1M penalty and trains leaders
To resolve an HSR Act violation, Amedisys must pay a $1,100,000 civil penalty within 30 days of the Court's entry of the Final Judgment and provide antitrust compliance training for corporate leadership, their direct reports, and certain field leadership across all lines of business.
Possible extra divestitures tied to CMS approvals
Six of the divested home health locations share licenses or CMS identification numbers with locations UnitedHealth keeps. If those six cannot obtain the regulatory approvals to operate as they did on July 17, 2025, or to bill CMS for Medicare or Medicaid patients, UnitedHealth may be required to divest up to eight additional home health locations.
Court monitor and enforcement tools to ensure compliance
The Final Judgment provides for a court-appointed monitor (William Berlin was appointed) to investigate and report at least every 90 days and gives the United States rights to enforce the order, including seeking contempt. This oversight aims to make sure the divestitures happen as required.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16850, United States of America, et al. v. CRH PLC, et al. Proposed Final Judgment and Competitive Impact Statement
2026-16112, United States et al. v. Cal-Maine Foods, Inc. et al.; Proposed Final Judgment and Competitive Impact Statement
2026-14903, United States, et al. v. OhioHealth Corporation; Proposed Final Judgment and Competitive Impact Statement
The U.S. government and Ohio are taking on OhioHealth Corporation for using sneaky contract rules that stop insurers from offering cheaper health plans. OhioHealth must now remove these rules and promise not to use them again, helping more budget-friendly options reach patients. People have 60 days to share their thoughts before the court makes it official.
2026-14935, United States v. Edwards LifeSciences Corp. and Genesis MedTech Group Limited; Proposed Final Judgment and Competitive Impact Statement
The U.S. government says Edwards LifeSciences broke the rules when it bought JC Medical from Genesis MedTech. Edwards must pay $10 million, Genesis pays $2 million, and Edwards has to get approval before buying any company working on special heart valve devices in the U.S. This keeps the market fair and protects competition in heart health tech.
2026-14780, Notice Pursuant to the National Cooperative Research and Production Act of 1993-Mobile Satellite Services Association
The Mobile Satellite Services Association (MSSA) just updated its team by adding Creative5 Inc. from Taiwan and saying goodbye to Simnovus Corporation from North Carolina. These changes keep the group’s special legal protections in place, helping members avoid big antitrust lawsuits except for actual damages. If you’re part of MSSA or thinking about joining, keep an eye out—membership is open and updates will keep coming!
2026-14812, Notice Pursuant to the National Cooperative Research and Production Act of 1993-Expeditionary Missions Consortium-Crane
The Expeditionary Missions Consortium–Crane just added a bunch of new members and said goodbye to one. This update keeps their special legal protections in place, so if anyone tries to sue them over competition issues, they can only claim actual damages. No big money changes or project shifts, and they’ll keep sharing membership updates as they happen.
Previous / Next Documents
Previous: 2025-20310, Sunshine Act Meetings
The Legal Services Corporation (LSC) Board will hold a virtual meeting on November 20, 2025, with parts open to the public via YouTube. They’ll share important reports, vote on key documents, and honor members of their Rural Justice Task Force. Some discussions about future meetings will be private, but no new costs or deadlines are expected from this session.
Next: 2025-20312, Fresh Mushrooms From Canada; Revised Schedule for the Subject Proceeding
The U.S. International Trade Commission is updating the schedule for its investigation into fresh mushrooms from Canada. If you’re involved, note new deadlines for conference requests, testimony, and briefs—all wrapping up by late November. The Commission will make its early decisions by mid-December, which could affect trade rules and prices soon after.